Stocks Health care BNTC
NASDAQ · Health careBenitec Biopharma Inc. (BNTC)
It posted a net loss of $45.5M. In fiscal 2026 capital spending exceeded operating cash flow by $16.6M. At June 30, 2026 it held $180M in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on September 14, 2026.
What Benitec Biopharma Inc. does
Benitec Biopharma Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker BNTC.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | n/a | -$45.5M | -$0.98 | -$16.6M |
| 2025 | n/a | -$37.9M | -$1.05 | -$23.6M |
| 2024 | $0 | -$21.8M | -$1.22 | -$19.6M |
| 2023 | $75K | -$19.6M | -$3.13 | -$18M |
| 2022 | $73K | -$18.2M | -$8.39 | -$15.9M |
| 2021 | $59K | -$13.9M | -$12.15 | -$13.1M |
Latest SEC filings
What Benitec Biopharma Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 24, 2026Auditor change 8-K
- September 14, 2026
- September 14, 2026Annual report 10-K · period to June 30, 2026
- September 14, 2026
- May 29, 2026
- May 14, 2026Quarterly report 10-Q · period to March 31, 2026
- May 14, 2026
- March 20, 2026Annual report (amended) 10-K/A · period to June 30, 2025
- February 12, 2026
- February 12, 2026Quarterly report 10-Q · period to December 31, 2025
Questions about BNTC
What does Benitec Biopharma Inc. do?
Benitec Biopharma Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker BNTC.
Is Benitec Biopharma Inc. profitable?
No. In fiscal 2026 it reported a net loss of $45.5M.
When did Benitec Biopharma Inc. last report?
Its most recent periodic report is the annual report (10-K) filed on September 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the auditor change from September 24, 2026.
Similar companies
Follow BNTC
Get an email when Benitec Biopharma Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow BNTC: get an email when it filesWhere the numbers come from
Financial figures are the values Benitec Biopharma Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.